The Staphylococcal-specific Antibiotic Debio 1450 Minimizes Disturbance to the Gut Microbiota in Mice

Presented at IDWeek 2016, New Orleans, LA, USA

J. Kuehn (1), F. Wittke (1), M. Barbier (1), S. Le Fresne (2), T. Carton (2), S. Leuillet (2), F. Le Vacon (2), G. Vuagniaux (1)

1. Debiopharm International SA, Switzerland;
2. Biofortis Mérieux NutriSciences, France.